• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅鞘细胞在脊髓损伤治疗中的临床应用

Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury.

作者信息

Rao Yaojian, Zhu Wenxiao, Liu Huijuan, Jia Chunxia, Zhao Qingan, Wang Yongjun

机构信息

Luoyang Orthopaedic-Traumatological Hospital, Luoyang, China.

出版信息

J Int Med Res. 2013 Apr;41(2):473-81. doi: 10.1177/0300060513476426. Epub 2013 Feb 11.

DOI:10.1177/0300060513476426
PMID:23569013
Abstract

OBJECTIVES

To investigate the safety and therapeutic efficacy of autologous olfactory ensheathing cell (OEC) transplantation in cervical spinal cord injury (SCI).

METHODS

Patients with cervical SCI of >6 months' duration were treated with autologous OECs, injected into the area surrounding the SCI under magnetic resonance imaging guidance, twice a week for 4 weeks. Patients were evaluated before treatment and at 3, 6, 12 and 24 months post-treatment, using the American Spinal Injury Association (ASIA) Impairment Scale, the ASIA sensory and motor score and the Functional Independence Measure (FIM) score.

RESULTS

Eight patients were recruited to the study. Three months after treatment, ASIA and FIM scores had improved significantly compared with pretreatment, though by 1 year no further significant improvements in the ASIA score were seen. The return of substantial sensation and motor activity in various muscles below the injury level was observed in three patients during follow-up. In addition, bladder function was restored in two patients. There were no serious complications postoperatively or during the follow-up period.

CONCLUSIONS

This study provides preliminary evidence of the safety and possible efficacy of autologous OEC transplantation.

摘要

目的

探讨自体嗅鞘细胞(OEC)移植治疗颈脊髓损伤(SCI)的安全性和疗效。

方法

对病程超过6个月的颈脊髓损伤患者,在磁共振成像引导下将自体嗅鞘细胞注入脊髓损伤部位周围,每周两次,共4周。在治疗前以及治疗后3、6、12和24个月,使用美国脊髓损伤协会(ASIA)损伤量表、ASIA感觉和运动评分以及功能独立性测量(FIM)评分对患者进行评估。

结果

8名患者被纳入该研究。治疗3个月后,与治疗前相比,ASIA和FIM评分有显著改善,但到1年时,ASIA评分未见进一步显著改善。随访期间,3名患者损伤平面以下不同肌肉的大量感觉和运动活动恢复。此外,2名患者的膀胱功能恢复。术后及随访期间均无严重并发症。

结论

本研究为自体嗅鞘细胞移植的安全性和可能的疗效提供了初步证据。

相似文献

1
Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury.嗅鞘细胞在脊髓损伤治疗中的临床应用
J Int Med Res. 2013 Apr;41(2):473-81. doi: 10.1177/0300060513476426. Epub 2013 Feb 11.
2
Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury.自体嗅鞘细胞移植治疗完全性脊髓损伤。
Cell Transplant. 2013;22(9):1591-612. doi: 10.3727/096368912X663532.
3
Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury.六例慢性完全性脊髓损伤患者嗅鞘细胞移植的长期疗效。
Cell Transplant. 2013;22 Suppl 1:S21-5. doi: 10.3727/096368913X672127. Epub 2013 Aug 29.
4
Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.嗅鞘细胞移植治疗完全性慢性脊髓损伤患者的长期疗效。
Cell Transplant. 2012;21 Suppl 1:S23-31. doi: 10.3727/096368912X633734.
5
Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury.嗅黏膜自体移植和康复治疗慢性创伤性脊髓损伤。
Neurorehabil Neural Repair. 2010 Jan;24(1):10-22. doi: 10.1177/1545968309347685. Epub 2009 Sep 30.
6
Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI.慢性脊髓损伤患者胎儿嗅鞘细胞移植的安全性。MRI 38 个月随访。
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Apr;20(4):439-43.
7
Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial.酸性成纤维细胞生长因子修复人体脊髓损伤的临床试验。
J Neurosurg Spine. 2011 Sep;15(3):216-27. doi: 10.3171/2011.4.SPINE10404. Epub 2011 Jun 10.
8
Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury.慢性脊髓损伤后嗅鞘细胞移植功能改善的影响因素
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Apr;20(4):434-8.
9
Autologous olfactory ensheathing cell transplantation in human spinal cord injury.自体嗅鞘细胞移植治疗人类脊髓损伤
Brain. 2005 Dec;128(Pt 12):2951-60. doi: 10.1093/brain/awh657. Epub 2005 Oct 11.
10
Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial.自体嗅鞘细胞移植治疗人类截瘫:一项为期3年的临床试验。
Brain. 2008 Sep;131(Pt 9):2376-86. doi: 10.1093/brain/awn173. Epub 2008 Aug 8.

引用本文的文献

1
Effect of Dynamin-2 Gene Modified OECs on Functional and Molecular Neuroprotection After Spinal Cord Injury in Rats.发动蛋白2基因修饰的嗅鞘细胞对大鼠脊髓损伤后功能及分子神经保护的作用
Neurochem Res. 2025 Jul 16;50(4):232. doi: 10.1007/s11064-025-04491-y.
2
Adipose-derived stem cell therapy for spinal cord injuries: Advances, challenges, and future directions.脂肪来源干细胞治疗脊髓损伤:进展、挑战与未来方向。
Regen Ther. 2024 Jul 26;26:508-519. doi: 10.1016/j.reth.2024.07.007. eCollection 2024 Jun.
3
Activated Human Adipose Tissue Transplantation Promotes Sensorimotor Recovery after Acute Spinal Cord Contusion in Rats.
激活的人脂肪组织移植促进大鼠急性脊髓挫伤后的感觉运动功能恢复。
Cells. 2024 Jan 17;13(2):182. doi: 10.3390/cells13020182.
4
Use of Cells, Supplements, and Peptides as Therapeutic Strategies for Modulating Inflammation after Spinal Cord Injury: An Update.细胞、补充剂和肽在脊髓损伤后炎症调节中的治疗策略应用:更新。
Int J Mol Sci. 2023 Sep 11;24(18):13946. doi: 10.3390/ijms241813946.
5
Designing a Clinical Trial with Olfactory Ensheathing Cell Transplantation-Based Therapy for Spinal Cord Injury: A Position Paper.基于嗅鞘细胞移植疗法治疗脊髓损伤的临床试验设计:立场文件。
Biomedicines. 2022 Dec 6;10(12):3153. doi: 10.3390/biomedicines10123153.
6
Recovering Voiding and Sex Function in a Patient with Chronic Complete Spinal Cord Injury by Olfactory Ensheathing Cell Transplantation.嗅鞘细胞移植恢复慢性完全性脊髓损伤患者的排尿及性功能
Case Rep Neurol Med. 2022 Jul 6;2022:9496652. doi: 10.1155/2022/9496652. eCollection 2022.
7
Comparing the Efficacy and Safety of Cell Transplantation for Spinal Cord Injury: A Systematic Review and Bayesian Network Meta-Analysis.脊髓损伤细胞移植的疗效与安全性比较:系统评价与贝叶斯网络Meta分析
Front Cell Neurosci. 2022 Apr 4;16:860131. doi: 10.3389/fncel.2022.860131. eCollection 2022.
8
Cell Therapy for Neurological Disorders: The Perspective of Promising Cells.用于神经疾病的细胞疗法:有前景的细胞的视角
Biology (Basel). 2021 Nov 6;10(11):1142. doi: 10.3390/biology10111142.
9
Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database.慢性脊髓损伤神经功能恢复临床试验的入组时间:一项系统评价及ClinicalTrials.gov数据库的观察结果
Neural Regen Res. 2022 May;17(5):953-958. doi: 10.4103/1673-5374.324826.
10
Pharmacologic and Regenerative Cell Therapy for Spinal Cord Injury: WFNS Spine Committee Recommendations.脊髓损伤的药物治疗与再生细胞疗法:世界神经外科联合会脊柱委员会建议
Neurospine. 2020 Dec;17(4):785-796. doi: 10.14245/ns.2040408.204. Epub 2020 Dec 31.